These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21314177)

  • 1. DNA-gold nanoparticle reversible networks grown on cell surface marker sites: application in diagnostics.
    Lee K; Drachev VP; Irudayaraj J
    ACS Nano; 2011 Mar; 5(3):2109-17. PubMed ID: 21314177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labeled gold nanoparticles immobilized at smooth metallic substrates: systematic investigation of surface plasmon resonance and surface-enhanced Raman scattering.
    Driskell JD; Lipert RJ; Porter MD
    J Phys Chem B; 2006 Sep; 110(35):17444-51. PubMed ID: 16942083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
    Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-enhanced Raman scattering imaging of HER2 cancer markers overexpressed in single MCF7 cells using antibody conjugated hollow gold nanospheres.
    Lee S; Chon H; Lee M; Choo J; Shin SY; Lee YH; Rhyu IJ; Son SW; Oh CH
    Biosens Bioelectron; 2009 Mar; 24(7):2260-3. PubMed ID: 19056254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALDH(+)/CD44(+)/CD24(-) expression in cells from body cavity fluids.
    Krishan A; Sharma D; Sharma S; Hamelik RM; Ganjei-Azar P; Nadji M
    Cytometry B Clin Cytom; 2010 May; 78(3):176-82. PubMed ID: 20043317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas.
    Lü X; Xu K; Lü H; Yin Y; Ma C; Liu Y; Li H; Suo Z
    Ultrastruct Pathol; 2011 Apr; 35(2):72-8. PubMed ID: 21299347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of SERS-fluorescence dual modal nanoprobes and application to multiplex cancer cell imaging.
    Lee S; Chon H; Yoon SY; Lee EK; Chang SI; Lim DW; Choo J
    Nanoscale; 2012 Jan; 4(1):124-9. PubMed ID: 22080302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment.
    Pandit TS; Kennette W; Mackenzie L; Zhang G; Al-Katib W; Andrews J; Vantyghem SA; Ormond DG; Allan AL; Rodenhiser DI; Chambers AF; Tuck AB
    Int J Oncol; 2009 Aug; 35(2):297-308. PubMed ID: 19578743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly controlled surface-enhanced Raman scattering chips using nanoengineered gold blocks.
    Yokota Y; Ueno K; Misawa H
    Small; 2011 Jan; 7(2):252-8. PubMed ID: 21213390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of biocompatible SERS nanotag with increased stability by chemisorption of reporter molecule for in vivo cancer detection.
    Maiti KK; Dinish US; Fu CY; Lee JJ; Soh KS; Yun SW; Bhuvaneswari R; Olivo M; Chang YT
    Biosens Bioelectron; 2010 Oct; 26(2):398-403. PubMed ID: 20801634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.
    Abraham BK; Fritz P; McClellan M; Hauptvogel P; Athelogou M; Brauch H
    Clin Cancer Res; 2005 Feb; 11(3):1154-9. PubMed ID: 15709183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status.
    Kim HJ; Kim MJ; Ahn SH; Son BH; Kim SB; Ahn JH; Noh WC; Gong G
    Breast; 2011 Feb; 20(1):78-85. PubMed ID: 20810282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical probing of single cancer cells with gold nanoaggregates by surface-enhanced Raman scattering.
    Tang HW; Yang XB; Kirkham J; Smith DA
    Appl Spectrosc; 2008 Oct; 62(10):1060-9. PubMed ID: 18926013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
    Bauerschmitz GJ; Ranki T; Kangasniemi L; Ribacka C; Eriksson M; Porten M; Herrmann I; Ristimäki A; Virkkunen P; Tarkkanen M; Hakkarainen T; Kanerva A; Rein D; Pesonen S; Hemminki A
    Cancer Res; 2008 Jul; 68(14):5533-9. PubMed ID: 18632604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine.
    Jain PK; Huang X; El-Sayed IH; El-Sayed MA
    Acc Chem Res; 2008 Dec; 41(12):1578-86. PubMed ID: 18447366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angular distribution of surface-enhanced Raman scattering from individual au nanoparticle aggregates.
    Shegai T; Brian B; Miljković VD; Käll M
    ACS Nano; 2011 Mar; 5(3):2036-41. PubMed ID: 21323329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?
    Fillmore C; Kuperwasser C
    Breast Cancer Res; 2007; 9(3):303. PubMed ID: 17540049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
    Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
    Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.